A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome
Introduction: Coronavirus disease 2019 (COVID-19) can have symptoms like many neurological diseases, and one of the rare forms of these presentations is opsoclonus-myoclonus ataxia syndrome (OMAS). The pathogenesis of OMAS in adults has not been clearly elucidated and OMAS can be fatal. Case pres...
Saved in:
| Main Authors: | Adalet Altunsoy, Nizamettin Kemirtlek, Halime Araz, Ebru Bilge Dirik, Esragül Akıncı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2024-02-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/17927 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Etiological Factors of Opsoclonus Myoclonus Ataxia Syndrome: A Single Center Experience with Eight Children
by: Veysel Gök, et al.
Published: (2022-12-01) -
Outcome of Opsoclonus-Myoclonus Syndrome
by: J Gordon Millichap
Published: (2011-09-01) -
Opsoclonus-myoclonus-ataxia syndrome as a complication of pembrolizumab treatment in an adult patient (a case report and literature review)
by: K. A. Rumiantseva, et al.
Published: (2023-03-01) -
Opsoclonus-Myoclonus Syndrome in Children: Modern Data
by: Irina F. Fedoseeva, et al.
Published: (2025-02-01) -
Opsoclonus-Myoclonus Outcome
by: J Gordon Millichap
Published: (1995-08-01)